Stereotactic radiotherapy of orbital metastasis from malignant melanoma: a case study

2014 ◽  
Vol 14 (2) ◽  
pp. 208-211
Author(s):  
Wojciech Majewski ◽  
Jerzy Wydmanski ◽  
Wojciech Rokicki

AbstractObjective:Orbital metastases lead to many distressful symptoms.Methods:A case-report of a 44-year-old woman with a melanoma metastasis in the orbital cavity, is reported. A patient presented with headache, proptosis and diplopia. The stereotactic radiotherapy of 19.5 Gy in three fractions using CyberKnife was performed. Follow-up examination 7 months later revealed satisfactory local control of the tumour, alleviation of orbital symptoms with no negative impact on visual function.Conclusion:Stereotactic radiotherapy seems to be a safe and effective treatment of orbital metastases from melanoma.

2011 ◽  
Vol 21 (1) ◽  
pp. 11-21 ◽  
Author(s):  
Farzan Irani ◽  
Rodney Gabel

This case report describes the positive outcome of a therapeutic intervention that integrated an intensive, residential component with follow-up telepractice for a 21 year old male who stutters. This therapy utilized an eclectic approach to intensive therapy in conjunction with a 12-month follow-up via video telepractice. The results indicated that the client benefited from the program as demonstrated by a reduction in percent stuttered syllables, a reduction in stuttering severity, and a change in attitudes and feelings related to stuttering and speaking.


HPB ◽  
2018 ◽  
Vol 20 ◽  
pp. S580-S581
Author(s):  
L. Ferreira ◽  
M. Achalandabaso ◽  
H. Alexandrino ◽  
J. Geoghegan ◽  
K. Conlon

Pharmateca ◽  
2021 ◽  
Vol 14_2021 ◽  
pp. 34-41
Author(s):  
Yu.Yu. Sergeev Sergeev ◽  
D.S. Beinusov Beinusov ◽  
V.V. Mordovtseva Mordovtseva ◽  
V.Yu. Sergeev Sergeev ◽  
◽  
...  

2020 ◽  
Vol 75 ◽  
pp. 372-375
Author(s):  
Gabriel Fridolin Hess ◽  
Katharina Glatz ◽  
Sacha I. Rothschild ◽  
Otto Kollmar ◽  
Savas Deniz Soysal ◽  
...  

2011 ◽  
Vol 17 (6) ◽  
pp. 669-671 ◽  
Author(s):  
Jin Ho Kim ◽  
Sang Yul Choi ◽  
Chul Koo Cho ◽  
Kwang Mo Yang ◽  
Woo Chul Noh ◽  
...  

2021 ◽  
Vol 7 (1) ◽  
pp. 9-12
Author(s):  
Neelam Singh ◽  
◽  
Alok Singh Sengar ◽  

A urinary tract infection is the most common bacterial infection met in day to day practice. It is more common in females than males due to shorter urethra which allows the bacteria quick access to the bladder. In Ayurveda symptoms of UTI has close resemblance with Mutrakruchha. Acharya Charaka has described eight types of Mutrakrichha. In Mutrakrichha, the vitiated Pitta dosha along with Apana Vayu reaches the Vasti (bladder) and afflicts the Mutravaha Srotas due to which the patient feels painful and burning micturition. In this case report a 45 years old female patient presenting with symptoms of urinary urgency, increased frequency and burning micturition on and off since 10 years was diagnosed as a case of recurrent UTI, managed effectively with chandraprabha vati, gokshuradi guggulu shwetparpati for 21days and uttarbasti procedure for 3days. The assessment were done before and after treatment showed significant changes in sign, symptoms and urine examination report. No recurrence of UTI was noticed in follow up visit. Ayurvedic management offers a good approach to manage Mutrakrichha.


2019 ◽  
Vol 4 (2) ◽  
pp. 157-162
Author(s):  
S. Wiryasaputra ◽  
J. G. Wong

Purpose: This report describes the development of focal choroidal excavation (FCE) and recurrent central serous chorioretinopathy (CSCR) following the treatment of choroidal neovascularization (CNV) years earlier. Methods: A case report is presented. Results: A 30-year-old man previously treated for an active CNV returned several years later with subacute metamorphopsia. Optical coherence tomography and angiography demonstrated no recurrence of the CNV but instead found an FCE and associated CSCR in its place. Conclusion: Longitudinal follow-up with multimodal imaging demonstrated FCE with recurrent CSCR as possible sequelae of treated CNV.


2019 ◽  
Vol 98 (8) ◽  
pp. 335-338

The authors describe a rare complication of ureteral stenting is the case study of a patient admitted to the hospital for congestion in the outlet system of both kidneys due to external ureteral compression by tumorous mass in the retroperitoneum. Histology confirmed the B-lymphoma of the retroperitoneum as a cause of the patient‘s problems. The ureteral stent was perforated in the course of inserting the stent into the ureter and the end of the splint was introduced into the inferior vena cava. The patient was asymptomatic, and this complication was detected as late as on day 12 on the follow-up CT scan. Stent extraction was without complications and without bleeding.


2018 ◽  
Vol 29 (1) ◽  
pp. 61-68
Author(s):  
Giulia Riva ◽  
Matteo Augugliaro ◽  
Gaia Piperno ◽  
Annamaria Ferrari ◽  
Elena Rondi ◽  
...  

Objectives: To evaluate the feasibility, in terms of acute toxicity and symptom control, of CyberKnife (Accuray, Sunnyvale, CA)-based stereotactic radiotherapy (CyberKnife-SRT) for metastatic orbital lesions. Methods: This retrospective study included patients with symptomatic metastases wholly located within the orbit. Palliative radiation treatment was performed using CyberKnife image-guided technology. Gross tumor volume was defined on a pre-radiotherapy magnetic resonance imaging. Acute and late toxicity was recorded according to Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer Scale. Results: Between April 2012 and July 2016, 21 patients underwent CyberKnife-SRT for 24 orbital metastases from different primary tumors. Median treatment dose was 18 Gy (15–24 Gy) given in a median of 3 fractions (2–3 fractions) with a median dose of 6 Gy/fraction (5–10 Gy/fraction). Acute grade 1 toxicity was observed in eight cases. No local recurrence occurred after median follow-up of 6.2 months (1.1–30.0 months) among 16 lesions that underwent post-stereotactic radiotherapy magnetic resonance imaging. All patients reported decreasing pre-stereotactic radiotherapy symptoms without late toxicity. Follow-up >6 months (median 22.8 months) was available for nine lesions; complete and partial radiological response was registered in four and five of them, respectively. Conclusion: In our experience, CyberKnife-SRT is a well-tolerated treatment that offers high local and symptom control in patients with intraocular and periocular malignant lesions.


Sign in / Sign up

Export Citation Format

Share Document